Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

-------------------

Net income (loss) 4,577 (1,930) 752 (6,313)

Redeemable convertible

preferred share accretion 417 735 1,973 2,156

------------------- -------------------

Income (loss) attributable to

common shareholders $ 4,160 $ (2,665) $ (1,221) $ (8,469)

------------------- -------------------

------------------- -------------------

Condensed Balance Sheets

(in thousands)

September 30, December 31,

2008 2007

(unaudited)

Assets:

Cash, cash equivalents and short

term investments $ 17,178 $ 5,131

Amounts and investment tax credit

receivable 1,375 1,813

Prepaid and other current assets 1,129 295

Property, equipment and other assets 566 111

----------------------------

Total assets $ 20,248 $ 7,350

----------------------------

----------------------------

Liabilities and stockholders' equity:

Accounts payable and accrued expenses $ 2,700 $ 1,048

Other current liabilities 905 4,665

Long term liabilities 1,163 2,487

Redeemable convertible preferred shares - 37,373

Stockh
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)...  ( www.competitivehealth.com ) — Competitive Health is pleased ... and advocacy service, has signed an agreement to become ... health services marketplace. 63% of Americans have ... expected to pay. As part of an ongoing effort ... is pleased to offer medical bill review and negotiation ...
(Date:12/22/2014)... Fertility Associates of Memphis has announced a ... a network of more than 20 contributing fertility ... fast access to a national pool of frozen ... Associates of Memphis is the only fertility clinic in ... Dr. William Kutteh , director of Fertility Associates ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the nation’s ... Pharm.D. to the newly created position of Vice President ... Dr. Maroulis will continue to manage the entire specialty ... pharmacies as the company expands. Dr. Maroulis has been ... has served in many different capacities in the pharmacy, ...
(Date:12/19/2014)... Calif. , Dec. 19, 2014 Bina Technologies, ... USA) announced today that they have been acquired by ... is a privately held company that provides a ... next generation sequencing (NGS) data for the academic and ... Roche Sequencing Unit, and will continue to focus on ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... at LSU, together with those at universities across the ... from the National Science Foundation (NSF). The Louisiana Alliance ... NSF support. , The alliance is led by LSU ... Astronomy and Randall Hall of the Department of Chemistry, ...
... OAKS, Calif., Nov. 1, 2010 Amgen (Nasdaq: ... Miletich, M.D., Ph.D., will urge members of a U.S. Food ... for biosimilars to establish approval standards that ensure patient safety ... and sound policy will follow," Dr. Miletich said.  "Amgen believes ...
... N.J., Nov. 1, 2010 PharmaNet Development Group, Inc., ... biotechnology, generic drug and medical device companies, today announced ... topics during the 9th Annual Partnerships in Clinical Trials ... in Vienna, Austria.   At the conference, ...
Cached Biology Technology:LSU researchers awarded 1 of the largest NSF grants in Louisiana history 2LSU researchers awarded 1 of the largest NSF grants in Louisiana history 3Amgen to Provide Testimony at FDA Hearing on Biosimilars 2Amgen to Provide Testimony at FDA Hearing on Biosimilars 3Amgen to Provide Testimony at FDA Hearing on Biosimilars 4PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna 2
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... the "Micro Market Monitor: North America Perimeter Security ... http://photos.prnewswire.com/prnh/20130307/600769 The North ... a CAGR of 3.6% from 2014 to 2019. Although ... market, Canada is expected to ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... team of scientists has discovered how changes in both ... of visual systems in African cichlid fish. ... of the journal PLoS Biology , Assistant Professor ... graduate student Kelly O,Quin, in the University of Maryland ...
... Microscopic ridges contouring the surface of flower petals ... pollinating insects can,t resist. Michigan State University scientists and ... The result could help researchers learn to enhance ... nanomaterials and "green chemical" feedstocks. "Surprisingly, our work ...
... may soon be able to wear contact lenses that ... by changing colours replacing the need to routinely ... developed by Chemical and Biochemical Engineering professor Jin Zhang ... nanoparticles embedded into the hydrogel lenses. These engineered ...
Cached Biology News:Seeing how evolutionary mechanisms yield biological diversity 2Seeing how evolutionary mechanisms yield biological diversity 3Michigan State University study sheds light on microscopic flower petal ridges 2
Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
... Rat adult normal paraffin tissue array ... or proteins of interest in extensive ... Rat brain, heart, kidney, liver, ... are arrayed on positively charged glass ...
... ml. Improves reproducibility and quality ... streaking.Eliminates extra spots caused by ... throughout entire 2-D runs, ensuring ... for both analytical and preparative ...
GENOMIPHI HY KIT 1000 RXN, 1 EA. Category: Genomics DNA Amplification....
Biology Products: